Tristan Rousselle holds a Ph.D. in cell biology from the University Joseph Fourier in Grenoble. He did part of his post graduated studies in Sussex University (Brighton-UK) and La Jolla Institute for Allergy and Immunology (San Diebo-CA) He co-founded in 2000 the company Protein’eXpert now called PX'Therapeutics. This biotechnology company is specialized in the engineering, pre-clinical and clinical development of therapeutic proteins. In 2011 PX'Therapeutics had more than 60 employees in Grenoble and Lyon and was realizing nearly 50% of its Turn Over outside Europe.
In July 2013, a few months after the Acquisition of PX Therapeutics by the “Laboratoire Aguettant” Tristan decided to launch a new venture with a lead innovative project in the field of Biosensors named “Aryballe”. He co-founded the company with Delphine Pau, Thierry Livache, Sam Guilaumé and Sissel Tolaas in March 2014. Since then Tristan holds the position of CEO at Aryballe Technologies SA which main objective is to develop the first universal and portable artificial Nose. In July 2016 & 2017 the company raised 3 M € with international investors and industrial partners. The first product, NeOse Pro has been launched in January 2018.
Awaiting presentation abstract.